BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:11 PM
 | 
Nov 17, 2009
 |  BC Extra  |  Clinical News

Isis falls after mipomersen update

Isis Pharmaceuticals Inc. (NASDAQ:ISIS) fell $2.28 (17%) to $11.12 on Tuesday after it and partner Genzyme Inc. (NASDAQ:GENZ) reported that four patients treated with mipomersen had elevations in liver transaminases above three times the...

Read the full 153 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >